Acton Pharmacy to sponsor mitochondrial-disease support group

Acton Pharmacy said late last week that it is partnering with MitoAction to support people with mitochondrial disease, a broad spectrum of disorders that affect an estimated 80,000 Americans. Acton Pharmacy will help expand outreach and support to mitochondrial disease patients by sponsoring MitoAction New England, a social and educational support group for patients and families in the area. Read More »

Allergan acquires development-stage medical device company Oculeve

Allergan, a global pharmaceutical company, announced Monday it has completed the acquisition of Oculeve, a development-stage medical device company focused on developing novel treatments for dry eye disease. Under the terms of the agreement, Allergan is acquiring Oculeve for a $125 million upfront payment and commercialization milestone payments related to Oculeve's lead development program, OD-01. Read More »